Quantifying premature ventricular contraction (PVC) frequency involves determining the number of PVCs within a defined period, typically expressed as a percentage of total heartbeats or as an absolute number per hour or 24 hours. The calculation assesses the proportion of heartbeats originating from ventricular ectopic foci compared to the total number of heartbeats. For example, a patient with 1000 PVCs in a 24-hour period and a total of 100,000 heartbeats would have a PVC frequency of 1%. This metric is crucial for evaluating the clinical significance of ventricular ectopy.
Assessing the extent of ventricular ectopy provides valuable information for risk stratification and guiding management strategies. Higher frequencies are often associated with increased risks of adverse cardiac events, including heart failure and sudden cardiac death, particularly in individuals with underlying structural heart disease. Historically, quantification has relied on Holter monitoring or event recorders, which provide continuous or intermittent electrocardiographic data over extended periods, facilitating comprehensive evaluation of ectopic activity. The determination of PVC frequency allows clinicians to assess the need for intervention, such as medication or ablation therapy.
